[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World journal of stem …, 2021 - pubmed.ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside.

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - europepmc.org
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - wjgnet.com
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - wjgnet.com
Figure 3 Detailed information of mesenchymal stem/stromal cell-based cytotherapy for
coronavirus disease 2019. A: Distribution of registered clinical trials among the countries for …